Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants

被引:3
|
作者
Curtiss, Frederic R. [1 ]
Fairman, Kathleen A. [1 ]
机构
[1] Acad Managed Care Pharm, CEBS, Alexandria, VA 22314 USA
来源
JOURNAL OF MANAGED CARE PHARMACY | 2010年 / 16卷 / 01期
关键词
HOSPITALIZATIONS; PREVENTION; INFECTION; OUTCOMES; CHILDREN;
D O I
10.18553/jmcp.2010.16.1.59
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [1] Palivizumab prophylaxis for respiratory syncytial virus in Canada:: utilization and outcomes
    Oh, PI
    Lanctôt, KL
    Yoon, A
    Lee, DSC
    Paes, BA
    Simmons, BS
    Parison, D
    Manzi, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 512 - 518
  • [2] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Candice Bjornson
    Parco Chan
    Abby Li
    Bosco Paes
    Krista L. Lanctôt
    Ian Mitchell
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1113 - 1118
  • [3] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Bjornson, Candice
    Chan, Parco
    Li, Abby
    Paes, Bosco
    Lanctot, Krista L.
    Mitchell, Ian
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (06) : 1113 - 1118
  • [4] Palivizumab Utilization and Compliance: Trends in Respiratory Syncytial Virus Prophylaxis in Florida
    Hampp, Christian
    Saidi, Arwa S.
    Winterstein, Almut G.
    [J]. JOURNAL OF PEDIATRICS, 2010, 156 (06): : 953 - U130
  • [5] Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
    Bosco Paes
    Mahwesh Saleem
    Doyoung Kim
    Krista L. Lanctôt
    Ian Mitchell
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 1561 - 1568
  • [6] Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
    Paes, Bosco
    Saleem, Mahwesh
    Kim, Doyoung
    Lanctot, Krista L.
    Mitchell, Ian
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (08) : 1561 - 1568
  • [7] Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    Pedraz, C
    Carbonell-Estrany, X
    Figueras-Aloy, J
    Quero, J
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : 823 - 827
  • [8] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    Vogel, AM
    Lennon, DR
    Broadbent, R
    Byrnes, CA
    Grimwood, K
    Mildenhall, L
    Richardson, V
    Rowley, S
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (06) : 550 - 554
  • [9] Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
    Pavilack, Melissa
    Clifford, Robert A.
    Gonzales, Tara
    Kong, Amanda M.
    Wade, Sally
    McLaurin, Kimmie K.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2018, 7 (01) : 121 - 134
  • [10] Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
    Melissa Pavilack
    Robert A. Clifford
    Tara Gonzales
    Amanda M. Kong
    Sally Wade
    Kimmie K. McLaurin
    [J]. Infectious Diseases and Therapy, 2018, 7 : 121 - 134